Skip to main content
. 2013 Sep 25;14:200. doi: 10.1186/1471-2369-14-200

Table 1.

Baseline characteristics of HD patients

HD patients
ESA ≤8,000 (units/week)
ESA >8,000 (units/week)
 
Hb ≥11 (g/dl)
Hb <11 (g/dl)
Hb ≥11 (g/dl)
Hb <11 (g/dl)
Number 380 264 158 211
Age (years)
64.5 (13.2)
64.1 (14.4)
64.9 (13.7)
64.2 (12.8)
Sex (%) men
60.4
56.1
65.0
56.4
Weight (kg)
70.6 (12.4)
72.0 (14.3)
74.1 (14.9)
73.6 (14.8)
ESA dose (units/week)
6,000 (4,000-8,000)
6,000 (4,000-8,000)
12,000 (10,000-16,000)
12,000 (12,000-18,000)
ERI (units/week/kg/Hb)
6.5 (2.9)
7.9 (3.4)
16.0 (6.3)
22.3 (13.5)
Primary kidney disease (%)
 
 
 
 
- Diabetes mellitus
10.6
17.4
16.5
15.6
- Glomerulonephritis
11.1
7.6
8.2
8.5
- Renal vascular disease
22.2
21.6
12.7
19.0
- Other
56.2
53.4
62.7
56.9
Comorbidity (%)
 
 
 
 
- Diabetes mellitus
17.1
20.8
27.2
24.2
- Malignancy
7.4
9.8
11.4
18.5
- Cardiovascular disease
39.2
41.3
32.9
40.8
Weekly Kt/V urea (Watson)
3.7 (0.9)
3.5 (0.9)
3.7 (0.8)
3.7 (1.0)
rGFR (ml/min/1.73 m2)
2.9 (1.5-4.4)
2.3 (0.8-3.8)
2.1 (0.8-4.2)
1.5 (0.4-3.2)
Nutritional status (SGA) (%)
 
 
 
 
- Severely malnourished
0.3
2.2
0.8
5.4
- Mild-moderate
19.1
25.4
27.1
37.3
- Well-nourished
80.6
72.4
72.0
57.2
Laboratory values
 
 
 
 
- Hemoglobin (g/dl)
12.1 (11.6-12.7)
10.3 (9.5-10.6)
12.1 (11.6-12.8)
9.8 (9.2-10.5)
- Albumin (g/l)
37.5 (4.5)
36.0 (4.9)
35.6 (4.5)
34.1 (6.0)
- Ferritin (μg/l)
190 (104–380)
175 (94–379)
229 (121–434)
257 (118–511)
- PTH (pmol/l)
12.1 (5.5-23.8)
10.6 (4.7-23.9)
16.3 (6.4-33.7)
10.0 (3.2-23.4)
- CRP (mg/l) 6.0 (3.0-12.0) 6.0 (3.0-15.0) 9.0 (3.0-17.0) 14.0 (6.0-34.5)

Values are presented as mean (SD), median (IQR) or percentage.